NCT00541931

Brief Summary

We are seeking healthy female volunteers to determine if multinutrient supplementation affects visible signs of skin aging as well as blood measurements of aging. We are seeking smokers and non-smokers.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
37

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2007

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2007

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

October 5, 2007

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 10, 2007

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2008

Completed
3.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2012

Completed
5.9 years until next milestone

Results Posted

Study results publicly available

November 20, 2017

Completed
Last Updated

November 20, 2017

Status Verified

November 1, 2017

Enrollment Period

5 months

First QC Date

October 5, 2007

Results QC Date

February 5, 2015

Last Update Submit

November 15, 2017

Conditions

Outcome Measures

Primary Outcomes (2)

  • Fold Change in Long Chain Fatty Acids

    Peripheral blood long chain fatty acids were measured. Fold change of 1 = no difference; if metabolites decrease at week 12 from baseline, the fold change will be \<1.

    Baseline; Week 12

  • Change in Fine Wrinkling

    Assessed by 4 dermatologists blinded to chronological age and smoking status, on a 10-point Likert scale (min 1/max 10); lower scores indicate less wrinkling and higher scores indicate more wrinkling. Values are the average of scores given by the four raters. Change was calculated as the baseline value minus the week 12 value.

    Baseline; week 12

Study Arms (2)

Nonsmoker

OTHER

Nonsmokers Intervention: Dietary Supplement: LifePak Nano

Drug: Dietary Supplement: LifePak Nano

Smoker

OTHER

Smoker arm Intervention: Dietary Supplement: LifePak Nano

Drug: Dietary Supplement: LifePak Nano

Interventions

Daily use

Also known as: Life Pak Nano
NonsmokerSmoker

Eligibility Criteria

Age18 Years - 70 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Nonpregnant Females, age 18-30 or 50-70
  • Body Mass Index Normal or Overweight
  • If age 18-30, must be non-smoker

You may not qualify if:

  • Use of anti-aging medications within 3 months of enrollment
  • Use of over-the-counter anti-aging creams (not sunscreens) more than once per week within one month of enrollment
  • Use of dietary supplements including vitamins within one month of enrollment
  • Use of tanning beds or excessive UV exposure (greater than 2 hours per day) within one month of enrollment
  • Use of sunless tanners within one month of enrollment
  • Uncontrolled or ongoing serious medical condition
  • Participation in another clinical study involving use of an investigational drug or product
  • Medical condition which, at the discretion of the investigator, will have a significant impact on ability to judge participant's skin characteristics, including age.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stanford University School of Medicine

Stanford, California, 94305, United States

Location

Related Publications (1)

  • Spitale RC, Cheng MY, Chun KA, Gorell ES, Munoz CA, Kern DG, Wood SM, Knaggs HE, Wulff J, Beebe KD, Chang AL. Differential effects of dietary supplements on metabolomic profile of smokers versus non-smokers. Genome Med. 2012 Feb 23;4(2):14. doi: 10.1186/gm313.

MeSH Terms

Conditions

Skin Diseases

Condition Hierarchy (Ancestors)

Skin and Connective Tissue Diseases

Limitations and Caveats

Sample size limitation, short term nature of study

Results Point of Contact

Title
Dr. Anne Chang, MD
Organization
Stanford University

Study Officials

  • Dr. Anne Lynn S. Chang

    Stanford University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

October 5, 2007

First Posted

October 10, 2007

Study Start

October 1, 2007

Primary Completion

March 1, 2008

Study Completion

January 1, 2012

Last Updated

November 20, 2017

Results First Posted

November 20, 2017

Record last verified: 2017-11

Locations